Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study
The respiratory infection COVID-19 caused by the virus SARS CoV-2 has continued to be a major health problem worldwide and has caused more than a million mortalities. Even if the development of COVID-19 vaccines has shown much progress, efforts to find novel, natural anti-viral drugs should be pursu...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | Arabian Journal of Chemistry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1878535221004081 |
id |
doaj-e8e62d01691840afb12d183a4ccfa4b3 |
---|---|
record_format |
Article |
spelling |
doaj-e8e62d01691840afb12d183a4ccfa4b32021-09-03T04:44:20ZengElsevierArabian Journal of Chemistry1878-53522021-11-011411103393Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational studyAsmi Citra Malina A.R. Tassakka0Ophirtus Sumule1Muhammad Nasrum Massi2 Sulfahri3Marianti Manggau4Israini Wiyulanda Iskandar5Jamaluddin Fitrah Alam6Andi Dian Permana7Lawrence M. Liao8Faculty of Marine Science and Fisheries, Universitas Hasanuddin, Makassar 90245, Indonesia; Centre of Excellence for Development and Utilization of Seaweeds, Universitas Hasanuddin, Makassar 90245, Indonesia; Corresponding author.Faculty of Marine Science and Fisheries, Universitas Hasanuddin, Makassar 90245, Indonesia; Centre of Excellence for Development and Utilization of Seaweeds, Universitas Hasanuddin, Makassar 90245, IndonesiaFaculty of Medicine, Universitas Hasanuddin, Makassar 90245, Indonesia; Centre of Excellence for Development and Utilization of Seaweeds, Universitas Hasanuddin, Makassar 90245, IndonesiaFaculty of Mathematics and Natural Sciences, Universitas Hasanuddin, Makassar 90245, Indonesia; Centre of Excellence for Development and Utilization of Seaweeds, Universitas Hasanuddin, Makassar 90245, IndonesiaFaculty of Pharmacy, Universitas Hasanuddin, Makassar 90245, Indonesia; Centre of Excellence for Development and Utilization of Seaweeds, Universitas Hasanuddin, Makassar 90245, IndonesiaCentre of Excellence for Development and Utilization of Seaweeds, Universitas Hasanuddin, Makassar 90245, IndonesiaFaculty of Marine Science and Fisheries, Universitas Hasanuddin, Makassar 90245, Indonesia; Centre of Excellence for Development and Utilization of Seaweeds, Universitas Hasanuddin, Makassar 90245, IndonesiaFaculty of Pharmacy, Universitas Hasanuddin, Makassar 90245, IndonesiaGraduate School of Integrated Sciences for Life, Hiroshima University, Higashi Hiroshima 739-8528, JapanThe respiratory infection COVID-19 caused by the virus SARS CoV-2 has continued to be a major health problem worldwide and has caused more than a million mortalities. Even if the development of COVID-19 vaccines has shown much progress, efforts to find novel, natural anti-viral drugs should be pursued. Halymenia durvillei is a marine red alga widely distributed around Southeast Asia. This study aimed to develop new anti SARS CoV-2 compounds from ethanolic and ethyl acetate extracts of H. via a computational approach, focusing onthe inhibitory action against the main protease (3CL-Mpro). In this study, 37 compounds were extracted and identified by GC–MS analysis. The potentials of compounds 1–2 tetradecandiol and E,E,Z-1,3,12-nonadecatriene-5,14-diol were identified for therapeutic purposes based on our pharmacophore study, while cholest-5-En-3-Ol (3.Beta.)- had a high fitness score in molecular docking studies both in monomer and dimer state compared to the N3 inhibitor and remdesivir affinity scores. As these compounds show competitive affinity scores against the 3CL-Mpro, these natural compounds may be effective for the treatment of COVID-19 infection. The ADME and pharmacokinetic studies should also be employed to assess the ability of the natural compounds as oral drugs. These promising results have shown the potentials of H. durvillei as an alternative drug in addressing COVID-19 infection. Accordingly, further studies should explore the effectiveness of these active compounds.http://www.sciencedirect.com/science/article/pii/S1878535221004081COVID-19Natural products chemistryMolecular dockingPharmacophore |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Asmi Citra Malina A.R. Tassakka Ophirtus Sumule Muhammad Nasrum Massi Sulfahri Marianti Manggau Israini Wiyulanda Iskandar Jamaluddin Fitrah Alam Andi Dian Permana Lawrence M. Liao |
spellingShingle |
Asmi Citra Malina A.R. Tassakka Ophirtus Sumule Muhammad Nasrum Massi Sulfahri Marianti Manggau Israini Wiyulanda Iskandar Jamaluddin Fitrah Alam Andi Dian Permana Lawrence M. Liao Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study Arabian Journal of Chemistry COVID-19 Natural products chemistry Molecular docking Pharmacophore |
author_facet |
Asmi Citra Malina A.R. Tassakka Ophirtus Sumule Muhammad Nasrum Massi Sulfahri Marianti Manggau Israini Wiyulanda Iskandar Jamaluddin Fitrah Alam Andi Dian Permana Lawrence M. Liao |
author_sort |
Asmi Citra Malina A.R. Tassakka |
title |
Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study |
title_short |
Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study |
title_full |
Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study |
title_fullStr |
Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study |
title_full_unstemmed |
Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study |
title_sort |
potential bioactive compounds as sars-cov-2 inhibitors from extracts of the marine red alga halymenia durvillei (rhodophyta) – a computational study |
publisher |
Elsevier |
series |
Arabian Journal of Chemistry |
issn |
1878-5352 |
publishDate |
2021-11-01 |
description |
The respiratory infection COVID-19 caused by the virus SARS CoV-2 has continued to be a major health problem worldwide and has caused more than a million mortalities. Even if the development of COVID-19 vaccines has shown much progress, efforts to find novel, natural anti-viral drugs should be pursued. Halymenia durvillei is a marine red alga widely distributed around Southeast Asia. This study aimed to develop new anti SARS CoV-2 compounds from ethanolic and ethyl acetate extracts of H. via a computational approach, focusing onthe inhibitory action against the main protease (3CL-Mpro). In this study, 37 compounds were extracted and identified by GC–MS analysis. The potentials of compounds 1–2 tetradecandiol and E,E,Z-1,3,12-nonadecatriene-5,14-diol were identified for therapeutic purposes based on our pharmacophore study, while cholest-5-En-3-Ol (3.Beta.)- had a high fitness score in molecular docking studies both in monomer and dimer state compared to the N3 inhibitor and remdesivir affinity scores. As these compounds show competitive affinity scores against the 3CL-Mpro, these natural compounds may be effective for the treatment of COVID-19 infection. The ADME and pharmacokinetic studies should also be employed to assess the ability of the natural compounds as oral drugs. These promising results have shown the potentials of H. durvillei as an alternative drug in addressing COVID-19 infection. Accordingly, further studies should explore the effectiveness of these active compounds. |
topic |
COVID-19 Natural products chemistry Molecular docking Pharmacophore |
url |
http://www.sciencedirect.com/science/article/pii/S1878535221004081 |
work_keys_str_mv |
AT asmicitramalinaartassakka potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy AT ophirtussumule potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy AT muhammadnasrummassi potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy AT sulfahri potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy AT mariantimanggau potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy AT israiniwiyulandaiskandar potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy AT jamaluddinfitrahalam potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy AT andidianpermana potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy AT lawrencemliao potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy |
_version_ |
1717818146750988288 |